Schizophrenia is a mental health condition characterized by distorted thinking, perceptions, emotions, language, sense of self, and behavior. It is a serious disorder affecting individuals of all ages and can vary in severity and duration, often requiring long-term management.

Over time, research has advanced from viewing schizophrenia merely as a behavioral issue to understanding its complex mechanisms involving genetic, neurobiological, and environmental factors.

This evolving understanding has been crucial in developing current therapeutic approaches that aim to manage symptoms, improve overall functioning, and address the psychological components of the disorder.

iNGENū's team of experienced researchers and clinicians specializes in designing and conducting innovative studies. By leveraging enhanced trial design and comprehensive patient-centric strategies, we are committed to accelerating the development of new treatments for schizophrenia.